Sintilimab-Induced Myocarditis in a Patient with Gastric Cancer: A Case Report and Literature Review

Immune checkpoint inhibitors (ICIs) have emerged as a powerful and efficacious therapeutic approach for many cancer patients. Sintilimab is a fully human IgG4 monoclonal antibody that binds with programmed cell death receptor-1 (PD-1) to block its interaction with ligands, thereby enhancing the anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xin, Zeng, Ziyue, Cao, Jianlei, Li, Xianqing, Muhetaer, Muheremu, Jin, Zhili, Cai, Huanhuan, Lu, Zhibing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607029/
https://www.ncbi.nlm.nih.gov/pubmed/37887869
http://dx.doi.org/10.3390/jcdd10100422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607029/
https://www.ncbi.nlm.nih.gov/pubmed/37887869
http://dx.doi.org/10.3390/jcdd10100422

Ejemplares similares